Influence of Hypnoacupuncture on Early Perioperative Recovery
Influence of Perioperative Medical Hypnosis and Acupuncture on Early Postoperative Recovery
1 other identifier
interventional
60
1 country
1
Brief Summary
Perioperative stress is associated with various influences before and after surgery. Instead of benzodiazepines, patients can be calmed by non-pharmacological methods. One of these is perioperative medical hypnosis, which has also other beneficial effects such as lower opioid consumption, better wound healing, shorter hospital stays. Acupuncture is used for analgesia. Is is effective for preventing and treating nausea and vomiting. Hypothesis of the study is that perioperative acupuncture reduces the consumption of analgesics and anaesthetics during surgery. The investigators will also study the impact of acupuncture on postoperative nausea and vomiting and analgesic consumption in the postoperative recovery unit and the occurrence of postoperative delirium.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 3, 2021
CompletedFirst Posted
Study publicly available on registry
October 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2022
CompletedNovember 8, 2022
November 1, 2022
1.3 years
June 3, 2021
November 6, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative consumption of antiemetics in mg
Postoperative nausea and vomiting will be measured in mg of antiemetics in PACU
24 hours
Secondary Outcomes (2)
Postoperative consumption of analgesics in mg
24 hours
Degree of satisfaction
24 hours
Study Arms (3)
STANDARD
ACTIVE COMPARATORTCI anaesthesia with remifentanil (4-6 µg / ml) and propofol (4-6 µg / ml) Patients will receive an antiemetic (ondansetron 4 mg). The depth of anesthesia will be adjusted to maintain BIS values of 40-55. The remifentanil infusion will be adjusted according to the pain monitor values. Analgesia: piritramide 0.1 mg / kg and metamizole 2.5 g. PACU: Analgesia in VAS\> 3: piritramide 3 mg p.p. Antiemetic for POSB: metoclopramide 10 mg
CONTROL
ACTIVE COMPARATORTCI anaesthesia with remifentanil (4-6 µg / ml) and propofol (4-6 µg / ml) Group does not receive neither acupuncture nor antiemetics. The depth of anesthesia will be adjusted to maintain BIS values of 40-55. The remifentanil infusion will be adjusted according to the pain monitor values. Analgesia: piritramide 0.1 mg / kg and metamizole 2.5 g. PACU: Analgesia in VAS\> 3: piritramide 3 mg p.p. Antiemetic for POSB: ondansetron 4 mg.
STUDY
ACTIVE COMPARATORBefore surgery, one of the team members will talk to the patient and perform brief medical hypnosis to gain the patient's confidence in the method and teach him the method of relaxing and building an imaginary safe place where he feels comfortable and safe. Therapeutic communication through hypnosis will be used as an additional method in order to improve the well-being and comfort of the patient, reduce stress and use sedatives. TCI anaesthesia with remifentanil (4-6 µg / ml) and propofol (4-6 µg / ml) Patients will receive acupuncture (PC6 and LI4 bilaterally) and no antiemetic The depth of anesthesia will be adjusted to maintain BIS values of 40-55. The remifentanil infusion will be adjusted according to the pain monitor values. Analgesia: piritramide 0.1 mg / kg and metamizole 2.5 g. Removal of acupuncture needles at the end of operation PACU: Analgesia in VAS\> 3: piritramide 3 mg p.p. Antiemetic for POSB: ondansetron 4 mg
Interventions
Eligibility Criteria
You may qualify if:
- Patient consent
You may not qualify if:
- Psychosis
- No consent for the study
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
JASMINA MARKOVIC BOZIC, MD, PhD
UMC LJUBLJANA
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The participant and the outcomes assessor will not know which intervention was used
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator; assist. prof., MD, PhD
Study Record Dates
First Submitted
June 3, 2021
First Posted
October 5, 2021
Study Start
May 1, 2021
Primary Completion
August 31, 2022
Study Completion
August 31, 2022
Last Updated
November 8, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share